Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

NCT03062319 is registered in ClinicalTrials.gov with National Hospital Organization Osaka National Hospital as lead sponsor.

NCT NCT03062319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03062319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis
Lead sponsor
National Hospital Organization Osaka National Hospital
Phase
Phase 4
Overall status
Terminated
Start date
April 6, 2017
Completion date
July 18, 2023
Enrollment
321 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherothrombosis, atrial fibrillation, ischemic stroke